Molecular and Cellular Biochemistry

, Volume 285, Issue 1–2, pp 143–147

Effect of ascorbic acid on prevention of hypercholesterolemia induced atherosclerosis



The notion that oxidation of lipids and propagation of free radicals may contribute to the pathogenesis of atherosclerosis is supported by a large body of evidence. To circumvent the damage caused by oxygen free radicals, antioxidants are needed which provide the much needed neutralization of free radical by allowing the pairing of electrons. In this study we have investigated the effect of ascorbic acid, a water soluble antioxidant on the development of hypercholesterolemia induced atherosclerosis in rabbits. Rabbits were made hypercholesterolemic and atherosclerotic by feeding 100 mg cholesterol/day. Different doses of ascorbic acid were administered to these rabbits. Low dose of ascorbic acid (0.5 mg/100 g body weight/day) did not have any significant effect on the percent of total area covered by atherosclerotic plaque. However, ascorbic acid when fed at a higher dose (15 mg/100 g body weight/day) was highly effective in reducing the atherogenecity. With this dose the percent of total surface area covered by atherosclerotic plaque was significantly less (p < 0.001). This suggests that use of ascorbic acid may have great promise in the prevention of hypercholesterolemia induced atherosclerosis.


ascorbic acid atherosclerosis hypercholesterolemia 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Watanabe T, Pakala R, Katagiri T, Benedict CR: Lipid peroxidation product 4-hydroxy-2 nonenal acts synergistically with serotinin in inducing vascular smooth muscle cell proliferation. Atherosclerosis 155: 37–44, 2001.PubMedCrossRefGoogle Scholar
  2. 2.
    Stamler J, Wentworth D, Neaton JD: Is relationship between serum cholesterol and Risk of premature death from coronary heart disease continuous and grades. JAMA 256: 2823–2828, 1986.PubMedCrossRefGoogle Scholar
  3. 3.
    Lipid Research Clinics program: The Lipid Research Clinics coronary primary prevention trial results: I. Reduction in the incidence of coronary heart disease. JAMA 251 351–364, 1984.Google Scholar
  4. 4.
    Lipid Research Clinic Program: The Lipid Research Clinics coronary primary prevention trial results: II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251: 365–374, 1984.Google Scholar
  5. 5.
    Blankenhorn DM, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, CashinHemphill L: Beneficial effects of combined colestipol – niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 257: 3233–3240, 1987.PubMedCrossRefGoogle Scholar
  6. 6.
    Brown G, Albers JJ: Regression of coronary artery disease as a result of intensive lipid lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 323: 1289–1298, 1990.PubMedCrossRefGoogle Scholar
  7. 7.
    Buchwald H, Varco RL, Matts JP: Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the program on the surgical control of Hyperlipidemias (POSCH). N Engl J Med 323: 946–955, 1990.Google Scholar
  8. 8.
    Nikkila EA, Taskinen MR, Rehunen S, Harkonen M: Lipoprotein lipase activity in adipose tissue and skeletal muscle of runners: Relation to serum lipoproteins. Metabolism 27: 1661–1671, 1978.PubMedCrossRefGoogle Scholar
  9. 9.
    Witzhum JL: The oxidation hypothesis of atherosclerosis. Lancet 344: 793–795, 1994.CrossRefGoogle Scholar
  10. 10.
    Duthie GG, Wahle KWJ, James WPT: Oxidants and antioxidants and cardiovascular disease. Nutr Res Rev 2: 51–62, 1989.CrossRefPubMedGoogle Scholar
  11. 11.
    Carroll KK, Khor HT: Effects of level and type of dietary fat on incidence of mammary tumors induced in female Sprague-Dawley rats by 7,12 dimethylbenz (alpha) anthracene. Lipids 6: 415–420, 1971.PubMedGoogle Scholar
  12. 12.
    Rosenfeld ME, Tsukada T, Gown AM, Ross R: Fatty streak initiation in watanabe heritable hyperlipidemic and comparable hypercholesterolemic fat fed rabbits. Arteriosclerosis 7: 9–23, 1987.PubMedGoogle Scholar
  13. 13.
    Rosenfeld ME, Tsukada T, Chait A, Biermann EL, Gown AM, Ross R: Fatty streak expansion and maturation in watanabe heritable hyperlipidemic and comparably hypercholesterolemic fat fed rabbits. Arteriosclerosis 7: 24–34, 1987.PubMedGoogle Scholar
  14. 14.
    Gerrity RG, Naito HK, Richardson M, Schwartz CJ: Dietary induced atherogenesis in Swine. Am J Pathol 95: 775–792, 1979.PubMedGoogle Scholar
  15. 15.
    Faggioto A, Ross R: Studies of hypercholesterolemia in non human primates. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis 4: 341–356, 1984.Google Scholar
  16. 16.
    Masuda J, Ross R: Atherogenesis during low level of hypercholesterolemia in the non human primate. I. Fatty streak formation. Arteriosclerosis 10: 164–177, 1990.PubMedGoogle Scholar
  17. 17.
    Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R: Apo E deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14: 133–140, 1994.PubMedGoogle Scholar
  18. 18.
    Das S, Lata S, Srivastava LM: Effect of ascorbic acidon lipid profile and lipid peroxidation in hypercholesterolemic rabbits. Nutr Res 17: 231–241, 1997.CrossRefGoogle Scholar
  19. 19.
    Prasad K, Kalra J: Oxygen free radicals and hypercholesterolemic atherosclerosis: Effect of vitamin E. Am Heart J 125: 958–973, 1993.PubMedCrossRefGoogle Scholar
  20. 20.
    Mehmetcik G, Toker G, Uysal M:Endogenous and copper induced lipid peroxidation and antioxidant activity of serum in hypercholesterolemic subjects. Horm Metab Res 29: 63–65, 1997.PubMedCrossRefGoogle Scholar
  21. 21.
    Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenecity. N Engl J Med 320: 915–924, 1989.PubMedCrossRefGoogle Scholar
  22. 22.
    Carew TE, Schwenke DC, Steinberg D: Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidant in vivo can selectively inhibit low density lipoprotein degradation in macrophage rich fatty streaks and slow the progression of atherosclerosis in the watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci USA 84: 7725–7729, 1987.PubMedCrossRefGoogle Scholar
  23. 23.
    Rodriguez JA, Nespereira B, Perez-Ilzarbe M, Eguinoa E, Paramo JA: Vitamins C and E prevent endothelial VEGF and VEGFR-2 over expression induced by porcine hypercholesterolemic LDL. Cardiovasc Res 65: 665–673, 2005.PubMedCrossRefGoogle Scholar
  24. 24.
    Roland Stocker, John F Keany Jr: Role of oxidative modifications in atherosclerosis. Physiol Rev 84: 1382–1478, 2004.CrossRefGoogle Scholar
  25. 25.
    Behzad Molavi and Jawahar L Mehta : Oxidative stress in cardiovascular disease: molecular basis of its deleterios effects, its detection and therapeutic considerations. Current opinion in Cardiology 19: 488–493, 2004.PubMedCrossRefGoogle Scholar
  26. 26.
    Viswanathan NM, Bhakthan NMG, Rockerbie RA: Effect of dietary supplementation of vitamin E on serum lipids and lipoproteins in rabbits fed a cholesterolemic diet. Int J Vitamin Res 49: 370–375, 1979.Google Scholar
  27. 27.
    Wojcicki J, Samochowice L, Jaworska M, Hinek A: A search for a model of experimental atherosclerosis: comparative studies in rabbits, guinea pigs and rats. Pol J Pharmacol Pharm 37: 11–21, 1985.PubMedGoogle Scholar
  28. 28.
    Sugano M, Nakashima Y, Tasaki H, Takasugi M, Kuroiwa A, Koide O: Effects of diltiazem on suppression and regression of experimental atherosclerosis. Br J Exp Pathol 69: 515–523, 1988.PubMedGoogle Scholar
  29. 29.
    Ohara Y, Peterson TE, Harrison DG: Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91: 2546–2551, 1993.PubMedCrossRefGoogle Scholar
  30. 30.
    Steinberg D: Antioxidants and atherosclerosis. A current assessment. Circulation 84: 1420–1425, 1991.PubMedGoogle Scholar
  31. 31.
    Parthasarathy S, Steinberg D, Witztum JL: The role of oxidized low density lipoproteins in the pathogenesis of atherosclerosis. Ann Rev Med 43: 219–225, 1992.PubMedCrossRefGoogle Scholar
  32. 32.
    Steinberg D: Antioxidants in the prevention of human atherosclerosis. Circulation 85: 2338–2345, 1992.Google Scholar

Copyright information

© Springer Science + Business Media, Inc. 2006

Authors and Affiliations

  • S. Das
    • 1
    • 5
  • R. Ray
    • 2
  • Snehlata
    • 3
  • N. Das
    • 1
    • 5
  • L. M. Srivastava
    • 1
    • 4
    • 5
  1. 1.Department of BiochemistrySir Ganga Ram HospitalNew DelhiIndia
  2. 2.Department of PathologySir Ganga Ram HospitalNew DelhiIndia
  3. 3.Department of Nuclear MedicineAll India Institute of Medical SciencesNew DelhiIndia
  4. 4.Department of BiochemistrySir Ganga Ram HospitalNew DelhiIndia
  5. 5.All India Institute of Medical SciencesNew DelhiIndia

Personalised recommendations